These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 37927030)

  • 1. Targeting the HIV reservoir: chimeric antigen receptor therapy for HIV cure.
    Li S; Wang H; Guo N; Su B; Lambotte O; Zhang T
    Chin Med J (Engl); 2023 Nov; 136(22):2658-2667. PubMed ID: 37927030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chimeric antigen receptor T-cell approaches to HIV cure.
    Kuhlmann AS; Peterson CW; Kiem HP
    Curr Opin HIV AIDS; 2018 Sep; 13(5):446-453. PubMed ID: 29878913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic Targeting of HIV Reservoirs: How to Give T Cells a New Direction.
    Yang H; Wallace Z; Dorrell L
    Front Immunol; 2018; 9():2861. PubMed ID: 30564246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV-1-Specific Chimeric Antigen Receptor T Cells Fail To Recognize and Eliminate the Follicular Dendritic Cell HIV Reservoir
    Ollerton MT; Berger EA; Connick E; Burton GF
    J Virol; 2020 May; 94(10):. PubMed ID: 32161179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opportunities for CAR-T Cell Immunotherapy in HIV Cure.
    Campos-Gonzalez G; Martinez-Picado J; Velasco-Hernandez T; Salgado M
    Viruses; 2023 Mar; 15(3):. PubMed ID: 36992496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of CAR-T cells for long-term eradication and surveillance of HIV-1 reservoir.
    Liu B; Zhang W; Zhang H
    Curr Opin Virol; 2019 Oct; 38():21-30. PubMed ID: 31132749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in Developing CAR T-Cell Therapy for HIV Cure.
    Qi J; Ding C; Jiang X; Gao Y
    Front Immunol; 2020; 11():361. PubMed ID: 32210965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toward T Cell-Mediated Control or Elimination of HIV Reservoirs: Lessons From Cancer Immunology.
    Mylvaganam G; Yanez AG; Maus M; Walker BD
    Front Immunol; 2019; 10():2109. PubMed ID: 31552045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CAR T cells: Living HIV drugs.
    Namdari H; Rezaei F; Teymoori-Rad M; Mortezagholi S; Sadeghi A; Akbari A
    Rev Med Virol; 2020 Nov; 30(6):1-14. PubMed ID: 32713110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of chimeric antigen receptor T cell therapy in non-human primates infected with SHIV or SIV.
    Iwamoto N; Patel B; Song K; Mason R; Bolivar-Wagers S; Bergamaschi C; Pavlakis GN; Berger E; Roederer M
    PLoS One; 2021; 16(3):e0248973. PubMed ID: 33752225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chimeric Antigen Receptor T Cells Guided by the Single-Chain Fv of a Broadly Neutralizing Antibody Specifically and Effectively Eradicate Virus Reactivated from Latency in CD4+ T Lymphocytes Isolated from HIV-1-Infected Individuals Receiving Suppressive Combined Antiretroviral Therapy.
    Liu B; Zou F; Lu L; Chen C; He D; Zhang X; Tang X; Liu C; Li L; Zhang H
    J Virol; 2016 Nov; 90(21):9712-9724. PubMed ID: 27535056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current status and future development of anti-HIV chimeric antigen receptor T-cell therapy.
    Mao Y; Zhao C; Zheng P; Zhang X; Xu J
    Immunotherapy; 2021 Feb; 13(2):177-184. PubMed ID: 33225803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stem cell-derived CAR T cells traffic to HIV reservoirs in macaques.
    Barber-Axthelm IM; Barber-Axthelm V; Sze KY; Zhen A; Suryawanshi GW; Chen IS; Zack JA; Kitchen SG; Kiem HP; Peterson CW
    JCI Insight; 2021 Jan; 6(1):. PubMed ID: 33427210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Broadly neutralizing antibody-derived CAR T cells reduce viral reservoir in individuals infected with HIV-1.
    Liu B; Zhang W; Xia B; Jing S; Du Y; Zou F; Li R; Lu L; Chen S; Li Y; Hu Q; Lin Y; Zhang Y; He Z; Zhang X; Chen X; Peng T; Tang X; Cai W; Pan T; Li L; Zhang H
    J Clin Invest; 2021 Oct; 131(19):. PubMed ID: 34375315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Challenges in HIV-1 Latent Reservoir and Target Cell Quantification in CAR-T Cell and Other Lentiviral Gene Modifying HIV Cure Strategies.
    Buck AM; Deveau TM; Henrich TJ; Deitchman AN
    Viruses; 2023 May; 15(5):. PubMed ID: 37243212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CAR Talk: How Cancer-Specific CAR T Cells Can Instruct How to Build CAR T Cells to Cure HIV.
    Kim GB; Hege K; Riley JL
    Front Immunol; 2019; 10():2310. PubMed ID: 31611880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Robust CAR-T memory formation and function via hematopoietic stem cell delivery.
    Zhen A; Carrillo MA; Mu W; Rezek V; Martin H; Hamid P; Chen ISY; Yang OO; Zack JA; Kitchen SG
    PLoS Pathog; 2021 Apr; 17(4):e1009404. PubMed ID: 33793675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Robust expansion of HIV CAR T cells following antigen boosting in ART-suppressed nonhuman primates.
    Rust BJ; Kean LS; Colonna L; Brandenstein KE; Poole NH; Obenza W; Enstrom MR; Maldini CR; Ellis GI; Fennessey CM; Huang ML; Keele BF; Jerome KR; Riley JL; Kiem HP; Peterson CW
    Blood; 2020 Oct; 136(15):1722-1734. PubMed ID: 32614969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolving Strategies to Eliminate the CD4 T Cells HIV Viral Reservoir
    York J; Gowrishankar K; Micklethwaite K; Palmer S; Cunningham AL; Nasr N
    Front Immunol; 2022; 13():873701. PubMed ID: 35572509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Trispecific Anti-HIV Chimeric Antigen Receptor Containing the CCR5 N-Terminal Region.
    Hajduczki A; Danielson DT; Elias DS; Bundoc V; Scanlan AW; Berger EA
    Front Cell Infect Microbiol; 2020; 10():242. PubMed ID: 32523897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.